DekaBank Deutsche Girozentrale Cuts Stock Holdings in Anthem, Inc. (NYSE:ANTM)
DekaBank Deutsche Girozentrale trimmed its position in shares of Anthem, Inc. (NYSE:ANTM) by 3.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,707 shares of the company’s stock after selling 3,213 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Anthem were worth $27,728,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the company. Fieldpoint Private Securities LLC acquired a new stake in Anthem in the 4th quarter valued at $25,000. Advisory Alpha LLC acquired a new stake in Anthem in the 3rd quarter valued at $30,000. Paces Ferry Wealth Advisors LLC acquired a new stake in Anthem in the 3rd quarter valued at $33,000. SOA Wealth Advisors LLC. acquired a new stake in Anthem in the 4th quarter valued at $36,000. Finally, Key Financial Inc acquired a new stake in Anthem in the 4th quarter valued at $37,000. 89.36% of the stock is owned by hedge funds and other institutional investors.
Shares of ANTM opened at $352.19 on Thursday. The firm has a market cap of $86.25 billion, a P/E ratio of 18.21, a price-to-earnings-growth ratio of 0.92 and a beta of 1.00. Anthem, Inc. has a 12-month low of $226.41 and a 12-month high of $379.13. The company’s 50-day moving average price is $334.15 and its 200 day moving average price is $311.87. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.56.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 25th. Investors of record on Wednesday, March 10th were issued a $0.95 dividend. The ex-dividend date was Tuesday, March 9th. This represents a $3.80 annualized dividend and a yield of 1.08%. Anthem’s dividend payout ratio (DPR) is currently 23.25%.
ANTM has been the topic of a number of research analyst reports. SVB Leerink lifted their price target on shares of Anthem from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, December 14th. Stephens lowered their target price on shares of Anthem from $350.00 to $340.00 and set an “overweight” rating on the stock in a research note on Thursday, January 28th. Jefferies Financial Group raised shares of Anthem from a “hold” rating to a “buy” rating and lifted their target price for the stock from $305.00 to $402.00 in a research note on Friday, January 15th. Truist Securities raised shares of Anthem from a “hold” rating to a “buy” rating and lifted their target price for the stock from $360.00 to $375.00 in a research note on Tuesday, March 9th. Finally, Credit Suisse Group lowered their target price on shares of Anthem from $389.00 to $382.00 and set an “outperform” rating on the stock in a research note on Thursday, January 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $359.81.
In other Anthem news, Director Ryan M. Schneider purchased 1,700 shares of the business’s stock in a transaction on Thursday, February 4th. The shares were bought at an average cost of $296.03 per share, for a total transaction of $503,251.00. Following the completion of the purchase, the director now directly owns 2,921 shares of the company’s stock, valued at $864,703.63. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Ronald W. Penczek sold 2,068 shares of the business’s stock in a transaction dated Friday, March 5th. The stock was sold at an average price of $333.94, for a total transaction of $690,587.92. Following the sale, the chief accounting officer now owns 3,137 shares in the company, valued at $1,047,569.78. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by insiders.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
Read More: Different Options Trading Strategies
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.